Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer's disease
| dc.creator | Pérez M.J. | |
| dc.creator | Ponce D.P. | |
| dc.creator | Osorio-Fuentealba C. | |
| dc.creator | Behrens M.I. | |
| dc.creator | Quintanilla R.A. | |
| dc.date.accessioned | 2020-09-02T22:25:46Z | |
| dc.date.accessioned | 2022-11-08T20:19:37Z | |
| dc.date.available | 2020-09-02T22:25:46Z | |
| dc.date.available | 2022-11-08T20:19:37Z | |
| dc.date.created | 2020-09-02T22:25:46Z | |
| dc.date.issued | 2017 | |
| dc.identifier | 11, OCT, - | |
| dc.identifier | 16624548 | |
| dc.identifier | https://hdl.handle.net/20.500.12728/5772 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143255 | |
| dc.language | en | |
| dc.publisher | Frontiers Media S.A. | |
| dc.subject | Alzheimer's disease | |
| dc.subject | Biomarker | |
| dc.subject | Fibroblasts | |
| dc.subject | Mitochondria | |
| dc.subject | OPA1 | |
| dc.subject | optic atrophy 1 protein | |
| dc.subject | regulator protein | |
| dc.subject | unclassified drug | |
| dc.subject | adult | |
| dc.subject | aged | |
| dc.subject | Alzheimer disease | |
| dc.subject | Article | |
| dc.subject | bioenergy | |
| dc.subject | brain mitochondrion | |
| dc.subject | cell fusion | |
| dc.subject | cell structure | |
| dc.subject | controlled study | |
| dc.subject | diagnostic test | |
| dc.subject | disease marker | |
| dc.subject | disorders of mitochondrial functions | |
| dc.subject | human | |
| dc.subject | human cell | |
| dc.subject | human cell culture | |
| dc.subject | middle aged | |
| dc.subject | protein degradation | |
| dc.subject | protein expression | |
| dc.subject | protein processing | |
| dc.subject | skin fibroblast | |
| dc.subject | very elderly | |
| dc.title | Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer's disease | |
| dc.type | Article |